Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes

Nature Immunology
Elmar JaeckelHarald von Boehmer

Abstract

Although autoimmune diseases can be initiated by immunization with a single antigen, it is not clear whether a single self antigen is essential for the initiation and, perhaps, the perpetuation of spontaneous autoimmunity. Some studies have suggested that insulin may represent an essential autoantigen in type 1 diabetes. Here we show that unlike tolerance to glutamic acid decarboxylase, tolerance to transgenically overexpressed preproinsulin 2 substantially reduced the onset and severity of type 1 diabetes in nonobese diabetic mice. However, some mice still developed type 1 diabetes, suggesting that insulin is a key, but not absolutely essential, autoantigen. The results are consistent with the idea that the human IDDM2 locus controls susceptibility to type 1 diabetes by regulating intrathymic preproinsulin expression.

References

Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z J ZhangH L Weiner
May 1, 1989·The Journal of Experimental Medicine·C BoitardJ F Bach
Apr 1, 1989·Journal of Autoimmunity·U Hurtenbach, C Maurer
Dec 1, 1994·Journal of Autoimmunity·D R WegmannD Daniel
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·T C WuD M Pardoll
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D Daniel, D R Wegmann
Jul 20, 1999·The Journal of Clinical Investigation·B CoonM G von Herrath
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·L YuG S Eisenbarth
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BotM von Herrath
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·W ChenT L Delovitch
Jan 10, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Peter A Gottlieb, George S Eisenbarth
May 31, 2002·The New England Journal of Medicine·UNKNOWN Diabetes Prevention Trial--Type 1 Diabetes Study Group
Jun 29, 2002·Nature Immunology·Irina ApostolouHarald von Boehmer
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Philippe HalboutChristian Boitard
Nov 9, 2002·Analytical Biochemistry·Jeannette WinterRainer Rudolph
Mar 18, 2003·The Journal of Clinical Investigation·Karine Thébault-BaumontChristian Boitard
May 3, 2003·The Journal of Clinical Investigation·Raymond J SteptoeLeonard C Harrison
Jun 11, 2003·The Journal of Experimental Medicine·Elmar JaeckelHarald von Boehmer
Jul 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ludger KleinHarald von Boehmer
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki MoriyamaGeorge S Eisenbarth
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Béatrice FaideauJean-Claude Carel
Feb 3, 2004·The Journal of Clinical Investigation·Sefina ArifMark Peakman
May 19, 2004·The Journal of Experimental Medicine·Irina Apostolou, Harald von Boehmer
Jun 9, 2004·The Journal of Experimental Medicine·Qizhi TangJeffrey A Bluestone
Jun 9, 2004·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman

❮ Previous
Next ❯

Citations

May 1, 2008·Current Diabetes Reports·Peter AchenbachUNKNOWN Pre-POINT Study Group
Jul 6, 2012·Current Diabetes Reports·Benno Weigmann, Carolin Daniel
Jul 8, 2011·Molecular Pharmaceutics·Frank AlderuccioBan-Hock Toh
Dec 18, 2009·Nature Immunology·Harald von Boehmer, Fritz Melchers
May 21, 2008·Nature Immunology·Harald von Boehmer
Jan 1, 2013·Nature Reviews. Drug Discovery·Harald von Boehmer, Carolin Daniel
Dec 2, 2004·Nature Reviews. Immunology·Bart O RoepMatthias von Herrath
Jul 20, 2007·Immunology and Cell Biology·Ayelet KaminitzNadir Askenasy
May 31, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Renxi WangYan Li
Jun 22, 2011·The Journal of Experimental Medicine·Carolin DanielHarald von Boehmer
Nov 9, 2011·The Journal of Experimental Medicine·James F MohanEmil R Unanue
Apr 7, 2009·Diabetes Technology & Therapeutics·Naru BabayaGeorge S Eisenbarth
Jul 10, 2010·Diabetes Technology & Therapeutics·Béla DénesWilliam H R Langridge
Mar 23, 2006·Annual Review of Immunology·Bruno Kyewski, Ludger Klein
May 4, 2006·The Journal of Clinical Investigation·Dirk Homann, George S Eisenbarth
Dec 5, 2006·The Journal of Clinical Investigation·Balasubramanian KrishnamurthyThomas W H Kay
Jul 4, 2007·The Journal of Clinical Investigation·Maki NakayamaGeorge S Eisenbarth
Apr 21, 2011·The Journal of Clinical Investigation·Christophe ViretSylvie Guerder
Mar 26, 2011·The Journal of Clinical Investigation·Huijuan LvMyra A Lipes
Feb 5, 2008·Genetics·Meng-Shin ShiaoHon-Tsen Yu
Jan 1, 2012·The Review of Diabetic Studies : RDS·Kate L GrahamThomas W H Kay
Feb 14, 2013·The Review of Diabetic Studies : RDS·Benno WeigmannCarolin Daniel
Aug 21, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Isabelle SerrCarolin Daniel
Feb 7, 2014·Annual Review of Immunology·Emil R Unanue
May 1, 2008·Current Diabetes Reports·Roberto Mallone, Peter van Endert
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Masakazu KobayashiGeorge S Eisenbarth
May 22, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Aaron W Michels, Maki Nakayama
Sep 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Anthony N VomundEmil R Unanue
Jul 5, 2011·Seminars in Immunology·Carolin Daniel, Harald von Boehmer
Feb 27, 2008·Diabetes·Amanda R BurtonDario A A Vignali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.